as 11-20-2024 4:00pm EST
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Founded: | 1952 | Country: | United States |
Employees: | N/A | City: | HERCULES |
Market Cap: | 9.1B | IPO Year: | N/A |
Target Price: | $411.00 | AVG Volume (30 days): | 211.4K |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -27.41 | EPS Growth: | N/A |
52 Week Low/High: | $262.12 - $387.99 | Next Earning Date: | 10-30-2024 |
Revenue: | $2,580,209,000 | Revenue Growth: | -5.15% |
Revenue Growth (this year): | -2.44% | Revenue Growth (next year): | 3.61% |
BIO Breaking Stock News: Dive into BIO Ticker-Specific Updates for Smart Investing
Insider Monkey
8 days ago
Argus Research
9 days ago
Argus Research
16 days ago
Zacks
17 days ago
Simply Wall St.
19 days ago
Simply Wall St.
20 days ago
Thomson Reuters StreetEvents
21 days ago
Morningstar Research
21 days ago
The information presented on this page, "BIO Bio-Rad Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.